fax: ++49 228 287 19718
Liver Failure/Cirrhosis/Portal Hypertension
Role of β3-adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis†
Version of Record online: 10 AUG 2009
Copyright © 2009 American Association for the Study of Liver Diseases
Volume 50, Issue 6, pages 1924–1935, December 2009
How to Cite
Trebicka, J., Hennenberg, M., Schulze Pröbsting, A., Laleman, W., Klein, S., Granzow, M., Nevens, F., Zaagsma, J., Heller, J. and Sauerbruch, T. (2009), Role of β3-adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis. Hepatology, 50: 1924–1935. doi: 10.1002/hep.23222
Potential conflict of interest: Nothing to report.
- Issue online: 20 NOV 2009
- Version of Record online: 10 AUG 2009
- Accepted manuscript online: 10 AUG 2009 12:00AM EST
- Manuscript Accepted: 27 JUL 2009
- Manuscript Received: 4 FEB 2009
- BONFOR. Grant Numbers: O-107.0084, O-107.0103
- Deutsche Forschungsgemeinschaft. Grant Number: SFB TRR57
Additional Supporting Information may be found in the online version of this article.
|HEP_23222_sm_SuppFig.tif||371K||Supporting Figure 1: Hepatic protein expression of β3-AR and GAPDH (as internal control) in cirrhotic patients compared to non-cirrhotic patients determined by Western blot analysis (A). Western blot of entire membranes of these samples are shown in Figure B and C using two different primary antibodies for β3-AR (ADI and Santa Cruz). Protein expression of β3-AR in primary rat liver cells (D), as well as in livers of cirrhotic BDL and CCl4 (E) rats were determined by Western blot analysis using two different primary antibodies (ADI and Santa Cruz).|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.